Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration

Life Sciences

Volumn 72, Issue 15, 2003, Pages 1665-1682

  Hensler, Julie G ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

5 HT1A receptor; Agonist treatments; Antidepressants

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ADENYLATE CYCLASE; AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CLOMIPRAMINE; GEPIRONE; GUANINE NUCLEOTIDE BINDING PROTEIN; IMIPRAMINE; ION CHANNEL; MAPROTILINE; MIRTAZAPINE; NEFAZODONE; NEUROTRANSMITTER; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; TRAZODONE; VENLAFAXINE; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; BRAIN CORTEX; BRAIN REGION; DRUG EFFICACY; DRUG MECHANISM; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; MOOD DISORDER; NEUROTRANSMISSION; NONHUMAN; PHOSPHORYLATION; SEROTONINERGIC SYSTEM; SHORT SURVEY; ANIMAL; BRAIN LEVEL; DRUG EFFECT; NERVE ENDING; REVIEW;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN CHEMISTRY; HUMANS; NERVE ENDINGS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0037469488     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02482-7     Document Type: Short Survey

References (118)

1. Aghajanian G.K., Sprouse J.S., Sheldon P., Rasmussen K. Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms. Annals of the New York Academy of Science. 600:1990;93-103.
2. 1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology. 14:1996;19-25.
3. B receptors to the same channels in hippocampus. Science. 234:1986;1261-1265.
4. Andrade R., Nicoll R.A. Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus. Naunyn-Schmiedeberg's Archives of Pharmacology. 336:1987;5-10.
5. Artigas F., Celada P., Laruelle M., Adell A. How does pindolol improve antidepressant action? Trends in Pharmacological Sciences. 22:2001;224-228.
6. Artigas F., Romero L., De Montigny C., Blier P. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends in Neuroscience. 19:1996;378-383.
7. Barr A.J., Brass L.F., Manning D.R. Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells. A direct evaluation of selectivity in receptor-G protein coupling. Journal of Biological Chemistry. 272:1997;2223-2229.
8. 3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. European Journal of Pharmacology. 178:1990;179-187.
9. Beique J., de Montigny C., Blier P., Debonnel G. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat. Neuropharmacology. 39:2000;1800-1812.
10. 1C receptor mediated behavior in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants. Psychopharmacology. 105:1991;219-224.
11. Blier P., Bergeron R. The use of pindolol to potentiate antidepressant medication. Journal of Clinical Psychiatry. 59:1998;16-23.
12. Blier P., de Montigny C. Effect of chronic tricyclic antidepressant treatment on the serotonergic autoreceptor. Naunyn-Schmiedeberg's Archives of Pharmacology. 314:1980;123-128.
13. Blier P., de Montigny C. Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. Journal of Neuroscience. 3:1983;1270-1278.
14. Blier P., de Montigny C. Serotonergic but not noradrenergic neurons in rat CNS adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience. 16:1985;949-955.
15. 1A agonist gepirone: Electrophysiological studies in the rat brain. Synapse. 1:1987;470-480.
16. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends in Pharmacological Science. 15:1994;220-226.
17. Blier P., Lista A., de Montigny C. Differential properties of pre-and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus. II. Effect of pertussis and cholera toxins. Journal of Pharmacology and Experimental Therapeutics. 265:1993;16-23.
18. Bockaert J., Dumuis A., Bouhelal R., Sebben M., Cory R.N. Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons. Naunyn-Schmiedeberg's Archives of Pharmacology. 335:1987;588-592.
19. Bohm S.K., Grady E.F., Bunnett N.W. Regulatory mechanisms that modulate signaling by G-protein-coupled receptors. Biochemistry Journal. 322:1997;1-18.
20. 1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe. European Journal of Pharmacology. 333:1997;147-157.
21. Bosker F.J., Cremers T.I., Jongsma M.E., Westerink B.H., Wikstrom H.V., den Boer J.A. Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala. Journal of Neurochemistry. 76:2001;1645-1653.
22. Butkerait P., Zheng Y., Hallak H., Graham T.E., Miller H.A., Burris K.D., Molinoff P.B., Manning D.R. Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammaliam G protein subunits. Journal of Biological Chemistry. 272:1995;2223-2229.
23. Ceci A., Baschirotto A., Borsini F. The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology. 33:1994;709-713.
24. A and glutamate receptors. Journal of Neuroscience. 21:2001;9917-9929.
25. 3H]8-OH-DPAT) binding. Journal of Pharmacology and Experimental Therapeutics. 266:1993;618-625.
26. Chaput Y., de Montigny C., Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 333:1986;342-348.
27. Chaput Y., de Montigny C., Blier P. Presynaptic and postsynpatic modifications of the serotonin system by long-term administration of antidepressant treatments. Neuropsychopharmacology. 5:1991;219-229.
28. + currents in rat serotonergic neurons. Journal of Physiology. 496.1:1996;129-137.
29. Clarke W.P., De Vivo M., Beck S.G., Maayani S., Goldfarb J. Serotonin decreases population spike amplitude in hippocampal cells through a pertussis toxin substrate. Brain Research. 410:1987;357-361.
30. Clarke W.P., Yocca F.D., Maayani S. Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats. Journal of Pharmacology and Experimental Therapeutics. 277:1996;1259-1266.
31. 1A agonists. Synapse. 14:1993;297-304.
32. de Montigny C., Aghajanian G.K. Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science. 22:1978;1303-1306.
33. de Montigny C., Blier P., Chaput Y. Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment. Neuropharmacology. 23:1984;1511-1520.
34. de Vivo M., Maayani S. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. Journal of Pharmacology and Experimental Therapeutics. 238:1986;248-253.
35. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology. 121:1995;1-26.
36. 1A receptor agonist. Journal of Pharmacology and Experimental Therapeutics. 284:1998;1082-1094.
37. 1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe. Naunyn-Schmiedeberg's Archives of Pharmacology. 356:1997;303-311.
38. Dong J., de Montigny C., Blier P. Full agonistic properties of BAY × 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe. Journal of Pharmacology and Experimental Therapeutics. 286:1998;1239-1247.
39. Eison A.S., Eison M.S., Torrente J.R., Wright R.N., Yocca F.D. Nefazodone: preclinical pharmacology of a new antidepressant. Psychopharmacology Bulletin. 26:1990;311-315.
40. Evrard A., Malagie I., Laporte A.M., Boni C., Hanoun N., Trillat A.C., Seif I., De Maeyer E., Gardier A., Hamon M., Adrien J. Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. European Journal of Neuroscience. 15:2002;841-851.
41. 1B receptors in knock-out mice lacking the 5-HT transporter. European Journal of Neuroscience. 12:2000;2299-2310.
42. Fabre V., Boutrel B., Hanoun N., Lanfumey L., Fattaccini C.M., Demeneix B., Adrien J., Hamon M., Martres M.-P. Homeostatic regulation of serotonergic function by the serotonin transporter as revealed by nonviral gene transfer. Journal of Neuroscience. 20:2000;5065-5075.
43. 1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography. Synapse. 12:1992;75-81.
44. 1A receptor modulation of anxiety in two ethological animal tests. Journal of Neuroscience. 16:1996;4810-4815.
45. Frazer A. Pharmacology of Antidepressants. Journal of Clinical Psychopharmacology. 2(Suppl. 1):1997;2S-18S.
46. Gartside S.E., Umbers V., Sharp T. Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms. Psychopharmacology. 130:1992;261-268.
47. Gobbi G., Murphy D.L., Lesch K.-P., Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: An in vivo electrophysiological study. Journal of Pharmacology and Experimental Therapeutics. 296:2001;987-995.
48. Godbout R., Chaput Y., Blier P., de Montigny C. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine: I. Effects of acute and long-term tandospirone on serotonin neurotransmission. Neuropharmacology. 30:1991;679-690.
49. Goodwin G.M., de Souza R.J., Green A.R. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Neuropharmacology. 24:1985;1187-1194.
50. Goodwin G.M., de Souza R.J., Green A.R. Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat. Psychopharmacology. 91:1987;500-505.
51. Gozlan H., El Mestikawy S., Pichat L., Glowinski J., Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature. 305:1983;140-142.
52. Gur E., Dremencov E., Van de Kar L.D., Lerer B., Newman M.E. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus. European Journal of Pharmacology. 436:2002;57-65.
53. 1A receptor-induced inhibition of 5-HT neuronal activity in the rat. British Journal of Pharmacology. 126:1999;1741-1750.
54. Hausdorff W.P., Caron M.G., Lefkowitz R.J. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB Journal. 4:1990;2881-2889.
55. 1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology. 26:2002;565-573.
56. 35S]GTPγS binding as measured by quantitative autoradiography following chronic agonist administration. British Journal of Pharmacology. 132:2001;605-611.
57. 1A receptor regulation: Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology. 4:1991;131-144.
58. 1A autoreceptors by a low chronic fluoxetine dose. Effect of the concurrent administration of WAY-100635. Neuropsychopharmacology. 24:2001;11-20.
59. Howell S.R., Hicks D.R., Scatina J.A., Sisenwine S.T. Pharmacokinetics of venlafaxine and o-desmethylvenlafaxine in laboratory animals. Xenobiotica. 24:1994;315-327.
60. B receptor-mediated inhibition of serotonergic neurons. European Journal of Pharmacology. 143:1987;195-204.
61. Johnson R.G., Fiorella D., Winter J.C., Rabin R.A. [3H]8-OH-DPAT labels a 5-HT site coupled to inhibition of phosphoinositide hydrolysis in the dorsal raphe. European Journal of Pharmacology. 329:1997;99-106.
62. 1A receptor agonist. Naunyn-Schmiedeberg's Archives of Pharmacology. 346:1992;121-126.
63. 1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. European Journal of Pharmacology. 138:1987;53-60.
64. Keppel Hesselink J.M. Promising Anxiolytics? A new class of drugs. Stahl S.M. Serotinin1A Receptors in Depression and Anxiety. 1992;171-183 Raven Press, New York.
65. Kia H.K., Miquel M.C., Brisorgueil M.J., Daval G., Riad M., El Mestikawy W., Hamon M., Verge D. Immunocyotchemical localization of serotonin1A receptors in the rat central nervous system. Journal of Comparative Neurology. 365:1996;289-305.
66. 1A receptor activation and antidepressant-like effects: F13714 has high efficacy and marked antidepressant potential. European Journal of Pharmacology. 420:2001;103-112.
67. 1A receptor-mediated effects of buspirone, gepirone, and ipsapirone. Pharmacology Biochemistry and Behavior. 29:1988;711-715.
68. Kreiss D.S., Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine. Journal of Pharmacology and Experimental Therapeutics. 274:1995;866-867.
69. 1A autoreceptors of the dorsal and median raphe nuclei. Synapse. 25:1997;107-116.
70. 1A receptor agonist 8-OH-DPAT. Neuropharmacology. 29:1990;85-91.
71. Le Poul E., Boni C., Hanoun N., Laporte A.M., Laaris N., Chauveau J., Hamon M., Lanfumey L. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology. 39:2000;110-122.
72. Lesch K.P., Aulakh C.S., Tolliver T.J., Hill J.L., Murphy D.L. Regulation of G proteins by chronic antidepressant drug treatment in rat brain: tricyclics but not clorgyline increase Goα European Journal of Pharmacology-Molecular Pharmacology Section. 207:1991;361-364.
73. Lesch K.P., Disselkapm-Tietze J., Schmidtke A. 5-HT1A receptor function in depression: effect of chronic amitriptyline treatment. Journal of Neural Transmission, General Section. 80:1990;157-161.
74. 1A agonist. Journal of Pharmacology and Experimental Therapeutics. 279:1996;1035-1042.
75. Li Q., Battaglia G., Van de Kar L.D. Autoradiographic evidence for differential G-protein coupling of 5-HT1A receptors in rat brain: lack of effect of repeated injuctions of fluoxetine. Brain Research. 769:1997;141-151.
76. Li Q., Wichems C., Heils A., Lesch K.P., Murphy D.L. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: Gender and Brain Region Differences. Journal of Neuroscience. 20:2000;7888-7895.
77. Lohse M.J. Molecular mechanisms of membrane receptor desensitization. Biochimica et Biophysica Acta. 1179:1993;171-188.
78. Lucki I., Frazer A. Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants. Psychopharmacology. 77:1982;205-211.
79. Lucki I. Behavioral studies of serotonin receptor agonists as antidepressant drugs. Journal of Clinical Psychiatry. 52:1991;24-31.
80. Maj J., Rogoz Z. Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha1-adrenergic, dopamine and serotonin systems. Journal of Neural Transmission. 106:1999;197-211.
81. 1A receptor-mediated regulation of dorsal raphe and hippocampal cell activity. Journal of Neuroscience. 21:2001;2178-2185.
82. 1A receptors in the rat brain. Soc. Neuroscience Abstracts #380.7. 2001.
83. 1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn Schmiedeberg's Archives of Pharmacology. 333:1986;335-341.
84. Marazziti D., Palego L., Giromella A., Mazzoni M.R., Borsini F., Mayer N., Naccarato A.G., Lucacchini A., Cassano G.B. Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain. International Journal of Neuropsychopharmacology. 5:2002;131-140.
85. 1A) receptors in the rat hippocampus: electrophysiological evidence. European Journal of Pharmacology. 141:1987;479-483.
86. 1A receptors and plasma corticosterone levels. General Pharmacology. 27:1996;355-361.
87. 1A agonists. Molecular Pharmacology. 37:1990;231-237.
88. Newman M.E., Ben-Zeev A., Lerer B. Choroamphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate cyclase in rat hippocampus. European Journal of Pharmacology-Molecular Pharmacology Section. 207:1991;209-213.
89. Newman M.E., Lerer B. Chronic electroconvulsive shock and desimipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes. European Journal of Pharmacology. 148:1988;257-260.
90. 1A agonists and antidepressants. Journal of Pharmacology and Experimental Therapeutics. 260:1992;16-20.
91. Palego L., Giromella A., Marazziti D., Borsini F., Naccarato A.G., Giannaccini G., Lucacchini A., Cassano G.B., Mazzoni M.R. Effects of postmortem delay on serotonin and (+)8-Oh-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues. Brain Research. 816:1999;165-174.
92. 35S]GTPγS autoradiography. British Journal of Pharmacology. 135:2002;1115-1122.
93. Penington N.J., Kelly J.S. Serotonin receptor activation reduces calcium current in an acutely dissociated adult central neuron. Neuron. 4:1990;751-758.
94. + currents activated by 5-HT1A receptors on dorsal raphe neurons of the adult rat. Journal of Physiology. 469:1993;387-405.
95. Prinssen E.P., Koek W., Colpaert F.C., Kleven M.S. Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. Behavioral Pharmacology. 11:2000;299-305.
96. Raap D.K., Evans S., Garcia F., Li Q., Muma N.A., Wolf W.A., Battaglia G., Van de Kar L.D. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. Journal of Pharmacology and Experimental Therapeutics. 288:1999;98-106.
97. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., Hen R. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences USA. 95:1998;14476-14481.
98. 1A receptors to inhibitory G protein α-subunits and lack of coupling to Gsα Biochemistry. 32:1993;11064-11073.
99. 1B serotonin receptors in adult rat brain. Journal of Comparative Neurology. 417:2000;181-194.
100. Riad M., Watkins K.C., Doucet E., Hamon M., Descarries L. Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). Journal of Neuroscience. 21:2001;8378-8386.
101. 1A receptors. European Journal of Pharmacology. 435:2002;195-203.
102. Sargent P., Williamson D.J., Pearson G., Odontiadis J., Cowen P.J. Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity. Psychopharmacology. 132:1997;296-302.
103. Schechter L.E., Bolanos F.J., Gozlan H., Lanfumey L., Haj-Dahmane S., Laporte A.-M., Fattaccini C.-M., Hamon M.J. Alterations of central serotonergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: Biochemical and electrophysiological studies. Journal of Pharmacology and Experimental Therapeutics. 255:1990;1335-1347.
104. 1A agonists. Journal of Pharmacology and Experimental Therapeutics. 270:1994;198-208.
105. Serres F., Li Q., Garcia F., Raap D.K., Battaglia G., Muma N.A., Van de Kar L.D. Evidence that Gz-proteins couple to hypothalamic 5-HT1A receptors in vivo. Journal of Neuroscience. 20:2000;3095-3103.
106. 35S]GTPγS binding in rat brain regions. Neuropharmacology. 42:2002;1031-1038.
107. 1A receptor-activated G-proteins in rat brain following chronic buspirone. European Journal of Pharmacology. 389:2000;147-153.
108. 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase. European Journal of Pharmacology. 154:1988;255-261.
109. Sotelo C., Cholley B., El Mestikawy S., Gozlan H., Hamon M. Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. European Journal of Neuroscience. 2:1990;1144-1154.
110. 1A receptor-related anxiolytics. Trends in Pharmacological Sciences. 8:1987;432-437.
111. Van de Kar L.D. Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annual Reviews of Pharmacology and Toxicology. 31:1991;289-320.
112. 1A-sensitive adenylyl cyclase of rodent hippocampal neurons: Effects of antidepressant treatments and chronic stimulation with agonists. Journal of Pharmacology and Experimental Therapeutics. 257:1991;433-438.
113. Vergé D., Daval G., Marcinkiewicz M., Patey A., El Mestikawy S., Gozlan H., Hamon M. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. Journal of Neuroscience. 6:1986;3474-3482.
114. Welner S.A., de Montigny C., Desroches J., Desjardins P., Suranyi-Cadotte B.E. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse. 4:1989;347-352.
115. Wieland S., Fischette C.T., Lucki I. Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors. Neuropharmacology. 32:1993;561-573.
116. Wozniak K.M., Aulakh C.S., Hill J.L., Murphy D.L. The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacology Biochemistry and Behavior. 30:1988;451-456.
117. 1A receptor mediated hypothermic response induced by 8-OH-DPAT in the rat. Progress in Neuropsychopharmacology and Biological Psychiatry. 18:1994;409-416.
118. 1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Molecular Pharmacology. 41:1992;1066-1072.